Luciano J. Costa, MD, PhD @End_myeloma @uabmedicine Associate Professor of Medicine, Blood and Marrow Transplantation and Cell Therapy, O’Neal Comprehensive Cancer Center, University of Alabama at Birmingham discusses how MRD can be used as a predictor of outcome.
MRD Predictor of Outcome @End_myeloma @uabmedicine
